Total Funding
69
59
Total FundingVenture - Series Unknown raised
Growth Score 69 in past quarter
-12 pts
Heat Score 59 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
150602
BioAscent operates a full compound management, logistics and shipping service from our modern, Automated Compound Store.
- Glenn Crocker: Non Executive DirectorPast Role: BioCity Group, Founder,CEO & Non-Executive Director
- Sylviane Boucharens: Chief Operating Officer and co-founder
About the Company
BioAscent, based at the former Organon / MSD R&D site in Newhouse, Scotland, UK, is a leading provider of integrated drug discovery services, including de novo assay development, target analysis and bespoke screening strategies, compound screening (including HTS), medicinal and synthetic chemistry, computational chemistry, and compound
management, all with access to in-house diversity and fragment libraries.
